Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade glioma

Although the successful clinical trials of immunotherapy show promising strategies for many cancers, its application in glioma has lagged in comparison with the progress seen in other cancers. Both isocitrate dehydrogenase (IDH) mutations and 1p/19q codeletions are critical molecular alterations aff...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wanzun, Qiu, Xianxin, Sun, Pian, Ye, Yuling, Huang, Qingting, Kong, Lin, Lu, Jiade J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167204/
https://www.ncbi.nlm.nih.gov/pubmed/34141867
http://dx.doi.org/10.1016/j.omto.2021.04.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167204/
https://www.ncbi.nlm.nih.gov/pubmed/34141867
http://dx.doi.org/10.1016/j.omto.2021.04.010

Ejemplares similares